Grant round · GrantConnect grant opportunity
Grant round GO5855
Awards in this round describe their activity in more than one way. The most common:
- “Bridging Barriers in Brain Cancer” (1 award)
- “Clinical Development of an Inhaled RNA Therapy for Chronic Lung Disease” (1 award)
- “Defeating Prostate Cancer with Targeted Alpha Therapy” (1 award)
- “Delivering precision medicine for lung cancer using plasma genomics ASPi-2L” (1 award)
- “Next generation cellular immunotherapy for multiple myeloma and beyond” (1 award)
$160m
whole-of-term value of 10 awards to 6 named recipients, published 2024-07-08 to 2026-06-30
$33m falls in 2026-27, from 10 active awards. estimate: annualised
A grant round is a grant opportunity on GrantConnect: an open or targeted call for applications under published guidelines. GrantConnect’s award lists give the opportunity’s ID but not its title; search GrantConnect for GO5855 to read its guidelines.
By agency
| Granting agency | Awards | Total value |
|---|---|---|
| Department of Health, Disability and Ageing | 7 | $107m |
| Department of Health and Aged Care | 3 | $53m |
Recipients, largest first
Recipients who are individuals, and awards that name no single recipient, are counted above but not listed, here or in the CSV. Why The bulk download has every award, with individuals flagged.
| Recipient | Awards | Total value |
|---|---|---|
| The University of Queensland | 3 | $43m |
| THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 2 | $40m |
| THE UNIVERSITY OF SYDNEY | 2 | $26m |
| ADVANCELL PTY LIMITED | 1 | $20m |
| UNIVERSITY OF MELBOURNE | 1 | $17m |
| MONASH UNIVERSITY | 1 | $15m |